Plato BioPharma, Inc.

Plato BioPharma, Inc. (PBI) is a pre-clinical drug discovery contract research organization (CRO).  Our decades of pharmaceutical and biotech industry experience result in a focused, data intensive, communicative approach that helps clients navigate the complex drug discovery process more rapidly and effectively.

PBI offers expert in vivo studies in four core therapeutic areas: cardiovascular, renal, pulmonary, and hepatic systems.  We utilize state-of-the-art data acquisition platforms, and offer a comprehensive suite of research services ranging from pharmacokinetics and target-based functional screens through complex proof-of-concept studies.

Plato BioPharma provides our clients with superior drug discovery research because we:

♦ appreciate the integrative nature within our core areas of expertise,
♦ advance partners discovery projects by providing multi system analysis of serial and endpoint functional, clinical chemistry and biomarker data,
♦ design our functional assays, disease models and studies to deliver clinically translatable drug discovery information, and
♦ generate constellations of data to enable deconvolution of target, compound, and disease model interaction.